Total Clarity Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Total Clarity Wealth Management's DGX Position: Q3 2021 in Review
Total Clarity Wealth Management sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 3,163 shares — an estimated $417K sold.
Total Clarity Wealth Management first reported a position in DGX in Q1 2021 and held it in 2 quarters. The position peaked at $417K in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- Total Clarity Wealth Management reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
- Total Clarity Wealth Management sold 3,163 Quest Diagnostics shares in Q3 2021, an estimated $417K.
- Total Clarity Wealth Management first reported a position in Quest Diagnostics in Q1 2021 and held it in 2 quarters.
- Total Clarity Wealth Management's Quest Diagnostics position peaked at $417K in Q2 2021.
- 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on Total Clarity Wealth Management's 13F filing for Q3 2021, filed 21 Oct 2021.